Open AccessRepeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome undergoing In Vitro fertilization cycles provides a better cycle outcome - a proof-of-concept study
Author(s) -
Daida Krishna,
Pookilath Baiju,
Praneesh Gautham,
R Suvarna,
Vohra Arveen,
Kamini A Rao
Publication year - 2017
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/jhrs.jhrs_102_17
Subject(s) - in vitro fertilisation , oocyte , polycystic ovary , luteinizing hormone , antral follicle , ovarian reserve , medicine , gonadotropin releasing hormone antagonist , hormone antagonist , andrology , ovarian hyperstimulation syndrome , gonadotropin , gonadotropin releasing hormone , gynecology , biology , hormone , pregnancy , infertility , embryo , insulin resistance , genetics , endocrine system , insulin , microbiology and biotechnology
Is a single dose of gonadotropin-releasing hormone agonist (GnRHa) trigger to induce final oocyte maturation in polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF) cycles with GnRH antagonist protocol sufficient to provide optimal oocyte maturity?